Skip to main content
. Author manuscript; available in PMC: 2014 Oct 16.
Published in final edited form as: J Eur Acad Dermatol Venereol. 2012 Oct 3;27(9):1163–1167. doi: 10.1111/j.1468-3083.2012.04703.x

Table 2. Relative risk of subsequent psoriasis by Mental Health Index score and anti-depression medication use.

86-100 Non-depressed 76-85 53-75 0-52 (Depressed) or medication use 0-52 (Depressed) and medication use
Self-reported psoriasis
Person-years 137,885 298,564 283,533 88,069 32,624
Psoriasis cases 73 232 245 64 41
Age-adjusted RR (95%CI) 1.00 1.48 (1.14,1.92) 1.65 (1.27,2.14) 1.82 (1.39,2.38) 2.36 (1.61,3.46)
Multivariate-adjusted RR (95%CI) 1.00 1.45 (1.11,1.89) 1.57 (1.21,2.04) 1.59 (1.21,2.08) 1.91 (1.30,2.81)
Confirmed psoriasis
Person-years 137,583 297,669 282,665 87,815 32,446
Psoriasis cases 35 122 130 33 21
Age-adjusted RR (95%CI) 1.0 1.62 (1.11,2.36) 1.83 (1.26,2.66) 1.90 (1.29,2.80) 2.51(1.46.4.31)
Multivariate-adjusted RR (95%CI) 1.0 1.59 (1.09,2.32) 1.75 (1.21,2.55) 1.68 (1.13,2.47) 2.07 (1.20,3.58)

Multivariate models simultaneously controlled for age (continuous), body mass index (<18.5, 18.5-24.9, 25-29.9, 30-34.9, ≥35 kg/m2), alcohol consumption (none, <4.9, 5.0-9.9, 10-14.9, 15-29.9 or ≥30.0 g/d), physical activity (metabolic equivalent hours/wk, quintiles), smoking status (never, current, past). The reference group was women with Mental Health Index score of 86-100 who were also not using anti-depression medications.